F AILURE of the circulation is associated with a number of interrelated factors tending to aggravate it and perpetuate its existence. It is generally accepted that low output failure leads to an increase in peripheral resistance due to reflex vasoconstriction. ' The increased peripheral resistance in turn adds to the work of the failing heart, thereby further decreasing its output.
In addition, diminished cardiac output mechanically induces a redistribution of total blood volume toward the larger veins of the circulation.' There is some evidence that constriction of smaller postarteriolar vessels may contribute to the venous engorgement.' The failing right heart is then subjected to excessive filling pressures, producing a further decrease in output. Thus, a vicious cycle is established. Diminished fig. 1) .
The therapeutic measures thus far available to interrupt this cycle have been directed at improving the function of the heart itself with digitalis, increasing the excretion of salt and water by use of mercurial diuretics, and direct reduction of venous engorgement by venesection or venous tourniquets. At the present time there are no recognized methods of lowering the peripheral resistance, thereby reducing the work of the failing heart, or of redistributing the total blood volume. This study was undertaken with a view toward decreasing the peripheral vascular resistance and central engorgement, using hexamethonium, a ganglionic blocking agent.2
MATERIALS AND METHODS
Nineteen patients with different types of heart disease in various degrees of congestive failure were studied at the Veterans Administration and Georgetown University Hospitals, Washington, D. C.
Peripheral venous pressure was measured in the antecubital vein with a saline manometer. The zero point was placed on a plane 10 cm. above the skin of the patient's back. In seven cases a polyethylene catheter was inserted into the antecubital vein and advanced to the level of the subelavian. Decholin was the indicator used in measuring the arm-totongue circulation time. The vital capacity was determined by means of a McKesscn-Scott Vital Capacity Apparatus. The blood pressure was measured by the auscultatory method. These procedures were employed immediately before the slow intravenous administration of hexamethonium and immediately after a satisfactory hypotensive response to the drug was observed. Aside from the general tendency towards slowing of the heart rate in the presence of normal sinus rhythm, the electrocardiographic tracings disclosed slight prolongation of the Chart showing an increase in cardiac output and decrease in right ventricular and systemic arterial pressures after, as compared to before, the intravenous administration of 8 mg. of hexamethonium ion to Cle, a white male, age 53, with hypertensive heart disease in congestive failure. Q-T interval in 8 of 14 cases. Minor T-wave deviations occurred in six instances. In the cases of auricular fibrillation mentioned above there was slowing of the "f" waves as seen best in lead V1 wXith a resultant increase in ventricular responses similar to that seen frequently following quinidine or procaine amide.
Cardiac catheterization studies were carried out in four patients with hypertensive heart disease in severe congestive failure (table 2) . In each instance there was a decrease in intracardiac or pulmonary arterial pressures which paralleled the fall in arterial pressure. Cardiac output, as determined by the direct Fick method, was performed in one case with heart failure ( fig. 2) Several workers4' 5 have observed that aminophylline similarly reduces elevated venous pressure. Howarth, McMichael and Sharpey-Schafer observed that the fall in right auricular pressure after aminophylline was comparable to that following the pooling of blood in the lower extremities using tourniquets, but there was a greater increase in cardiac output which was attributed to aminophylline's direct action on the myocardium. The effects were most readily observed in hypertensive heart failure.
During the hypotensive response to veratrum viride an increase in cardiac output and a decrease in pulmonary arterial pressure were observed to occur in hypertensive heart failure.' Others,7' 8 using tetraethylammonium, which blocks transmission of impulses through peripheral autonomic ganglia, demonstrated a fall in venous and arterial pressures both in hypertensive and nonhypertensive heart failure. There were no consistent changes in arm-to-tongue circulation time. Hayward7 as well as Lyons' noted decrease in dyspnea but this was not observed by Relman and Epstein.8
Priscoline, an adrenolytic and sympatholytic drug, also produced a decreased venous pressure in patients with congestive heart failure. However, the heart rate fell only in cases of cor pulmonale.10 Dresdale and his associates also observed in patients with primary pulmonary hypertension a more marked decrease in pulmonary vascular resistance following Priscoline than after tetraethylammonium.11 Perhaps Priscoline has some special effect in patients with heart failure associated with primary pulmonary hypertension.
It seems apparent that a variety of agents and procedures will produce a definite fall in venous pressure, right auricular and pulmonary arterial pressures when there is elevation initially. However, in contrast to results from venesection and with tetraethylammonium, the circulation time following hexamethonium improved. This is in keeping with a more complete return toward compensation in a failing heart.
Clinically in the long term therapy of severe hypertension using hexamethonium it has been observed that congestive heart failure when present is easier to control, and in occasional cases it has been possible to discontinue digitalis and mercurial diuretics. 12 It is suggested that hexamethonium may interrupt the congestive failure cycle at two points: (1) by decreasing the total peripheral resistance the work demand on the left vrentricle is lessened and (2) by reducing the filling pressure of the right heart the overloaded right ventricle is able to contract more effectively. The mechanism by which the right heart pressures diminish cannot be definitely established at present. It seems probable, however, that several factors may act conjointly. First, the increased output of the left ventricle resulting from the decreased peripheral resistance produces an unloading of the congested right heart and central veins. Second, blockade of vasoconstrictor reflexes may increase the vascular capacity as a consequence of peripheral vasodilatation, particularly of the postarteriolar vessels, thus producing a redistribution of the total blood volume.
These data supply additional suggestive evidence that the degree of constriction of the peripheral vessels may have an important influence on the function of the failing heart as originally suggested by McMichael.13 In addition, the beneficial effects of hexamethonium suggest that the adverse vasocontriction which occurs in heart failure may be under neurogenic control.
Since the conclusion of our study there has appeared a series of papers by Brod 3. It is suggested that hexamethonium, by reducing the total peripheral resistance and diverting blood volume to the peripheral vasculature, may interrupt the vicious cycle associated with congestive heart failure by, first, decreasing the work demand of the left ventricle and, second, reducing venous overloading of the right heart. SUMARIo ESPAROL Dosis hipotensas de hexamethonium fueron administradas intravenosamente a 19 pacientes con varias clases de enfermedades del corazo'n en decompensacion. Mejoramiento clinico juzgado por los metodos usuales se observo en la mayoria de los casos. Las presiones intracardiacas y de la arteria pulmonar decrecieron paralelamente a la presion arterial, luego de la administracion de hexamethonium en cuatro pacientes con enfermedad hipertensa del corazon con decompensacion cardiaca. Se sugiere que el hexamethonium, mediante reduccion de la resistencia periferica y mediante una redistribution del volumen de sangre puede interrumpir el ciclo vicioso de la decompensacion cardiaca.
